Goldman Sachs Put 250 AMG 17.01.2.../ DE000GZ7Z2A8 /
2024-12-23 9:09:26 AM | Chg.-0.170 | Bid4:40:28 PM | Ask4:40:28 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
0.190EUR | -47.22% | 0.190 Bid Size: 20,000 |
0.220 Ask Size: 20,000 |
AMGEN INC. DL-... | 250.00 - | 2025-01-17 | Put |
GlobeNewswire
08-29
Great Place To Work Announces the 2024 Best Workplaces in Asia Representing 6.9 Million Employee Exp...
GlobeNewswire
08-28
Prevent Cancer Annual Gala to celebrate three decades of commitment to cancer prevention and early d...
GlobeNewswire
08-15
Alvotech Reports Record Revenues and Adjusted EBITDA for the Second Quarter and First Six Months of ...
GlobeNewswire
08-12
TScan Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire
08-08
CytomX Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
08-08
Ardelyx Appoints Experienced Biopharma Executive, Eric Foster, as Chief Commercial Officer
GlobeNewswire
08-05
Avalyn Appoints Erin Lavelle, Seasoned Biopharma Finance Executive, to its Board of Directors
GlobeNewswire
08-01
CytomX Therapeutics to Report Second Quarter 2024 Financial Results on August 8, 2024